These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2536520)

  • 1. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast.
    Kamel OW; Franklin WA; Ringus JC; Meyer JS
    Am J Pathol; 1989 Jan; 134(1):107-13. PubMed ID: 2536520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki-67 labeling index is a more reliable measure of solid tumor proliferative activity than tritiated thymidine labeling.
    Deshmukh P; Ramsey L; Garewal HS
    Am J Clin Pathol; 1990 Aug; 94(2):192-5. PubMed ID: 2371973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.
    Meyer JS; Rao BR; Stevens SC; White WL
    Cancer; 1977 Nov; 40(5):2290-8. PubMed ID: 922670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidine labeling index in breast tumors.
    Lee HD; Soh EY; Chi HS; Kim BR; Lee KS; Song KS; Jung HJ
    Jpn J Surg; 1990 Mar; 20(2):180-5. PubMed ID: 1692890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell kinetics of histologic variants of in situ breast carcinoma.
    Meyer JS
    Breast Cancer Res Treat; 1986; 7(3):171-80. PubMed ID: 3022849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions.
    Terry G; Ho L; Londesborough P; Duggan C; Hanby A; Cuzick J
    Br J Cancer; 2007 Jan; 96(1):110-7. PubMed ID: 17164758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [S-phase fraction of benign mastopathies and breast carcinomas].
    Kunz J; Winzer KJ
    Zentralbl Chir; 1991; 116(7):483-6. PubMed ID: 1647602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling.
    McDivitt RW; Stone KR; Craig RB; Meyer JS
    Lab Invest; 1985 Mar; 52(3):287-91. PubMed ID: 2983150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study.
    Meyer JS; Prey MU; Babcock DS; McDivitt RW
    Lab Invest; 1986 Jan; 54(1):41-51. PubMed ID: 3941541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine labeling index: prognostic role in breast cancer.
    Bilir A; Ozmen V; Kecer M; Eralp Y; Cabioglu N; Ahishali B; Camlica H; Aydiner A
    Am J Clin Oncol; 2004 Aug; 27(4):400-6. PubMed ID: 15289735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations.
    Meyer JS; Coplin MD
    Am J Clin Pathol; 1988 May; 89(5):586-95. PubMed ID: 3358366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation index in various stages of breast cancer determined by Ki-67 immunostaining.
    Pence JC; Kizilbash AM; Kerns BJ; Marks JR; Iglehart JD
    J Surg Oncol; 1991 Sep; 48(1):11-20. PubMed ID: 1716331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell proliferation in fibrocystic disease and postmenopause breast ducts measured by thymidine labeling.
    Meyer JS; Connor RE
    Cancer; 1982 Aug; 50(4):746-51. PubMed ID: 7093909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis.
    Rudas M; Gnant MF; Mittlböck M; Neumayer R; Kummer A; Jakesz R; Reiner G; Reiner A
    Breast Cancer Res Treat; 1994; 32(2):165-75. PubMed ID: 7865846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tritiated thymidine labeling index of benign and malignant human breast epithelium.
    Meyer JS; Bauer WC
    J Surg Oncol; 1976; 8(2):165-81. PubMed ID: 1263520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the Tritiated Thymidine Labeling Index in breast cancers.
    Araki K; Kimura M; Sakamoto K; Nishimura R; Akagi M
    Jpn J Surg; 1985 Mar; 15(2):144-9. PubMed ID: 4010096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cell kinetic investigations in fibrocystic mastopathies and invasive breast carcinomas].
    Kunz J
    Acta Histochem Suppl; 1990; 39():175-9. PubMed ID: 2080259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for dissociation of viable human breast cancer cells that produces flow cytometric kinetic information similar to that obtained by thymidine labeling.
    McDivitt RW; Stone KR; Meyer JS
    Cancer Res; 1984 Jun; 44(6):2628-33. PubMed ID: 6327021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.
    Gerdes J; Lelle RJ; Pickartz H; Heidenreich W; Schwarting R; Kurtsiefer L; Stauch G; Stein H
    J Clin Pathol; 1986 Sep; 39(9):977-80. PubMed ID: 3020096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell kinetics and tumor-associated antigen expression in human mammary carcinomas.
    Contegiacomo A; Mariani Costantini R; Muraro R; Battista P; Valli C; Frati L; Calderopoli R; Zilembo N; Falco I; Petrella G
    Int J Biol Markers; 1991; 6(3):159-66. PubMed ID: 1665163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.